The Role of the Novel Oral Anticoagulants in the Secondary Prevention of Acute Coronary Syndromes

2015 ◽  
Vol 23 (2) ◽  
pp. 99-102
Author(s):  
Rajat Sharma ◽  
Kevin R. Bainey
Keyword(s):  
Secondary Prevention ◽  
Acute Coronary Syndromes ◽  
Oral Anticoagulants ◽  
Novel Oral Anticoagulants ◽  
The Novel ◽  
Coronary Syndromes

Novel Oral Anticoagulants After Acute Coronary Syndromes

2012 ◽  
Vol 26 (3) ◽  
pp. 265-271
Author(s):  
Newton B. Wiggins ◽  
Christopher B. Granger ◽  
John H. Alexander
Keyword(s):  
Acute Coronary Syndromes ◽  
Oral Anticoagulants ◽  
Novel Oral Anticoagulants ◽  
Coronary Syndromes

Thrombin and Platelets in Pulmonary Hypertension: A Lot More Than Clot

2012 ◽  
Vol 11 (1) ◽  
pp. 19-24
Author(s):  
R. James White
Keyword(s):  
Atrial Fibrillation ◽  
Pulmonary Hypertension ◽  
Venous Thrombosis ◽  
Oral Anticoagulants ◽  
Coagulation Factors ◽  
Novel Oral Anticoagulants ◽  
The Novel

This article is intended to deliver a clinically relevant overview about the role of coagulation factors and platelets in the pathogenesis of pulmonary hypertension. After summarizing the available data with warfarin, some information is provided about the novel oral anticoagulants that were recently approved for atrial fibrillation and may soon be approved for venous thrombosis. The author is hopeful that this information will stimulate investigator interest in this topic and drive us toward meaningful studies about this important aspect of PAH therapy.

Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?

2012 ◽  
Vol 7 (3) ◽  
pp. 195-208 ◽  
Author(s):  
Spyridon Deftereos ◽  
Georgios Bouras ◽  
Georgios Giannopoulos ◽  
Charalambos Kossyvakis ◽  
Vasiliki Panagopoulou ◽  
...  
Keyword(s):  
Acute Coronary Syndromes ◽  
Oral Anticoagulants ◽  
Novel Oral Anticoagulants ◽  
New Anticoagulants ◽  
Coronary Syndromes
Sign in / Sign up

Export Citation Format

Share Document